There are still controversies associated with BHRT, primarily because individual treatments and compounded hormones are not approved or regulated by the FDA. The reason for this is because each person receives a unique dosage, making it impossible for one regulating agency to monitor and approve each course of treatment.
Pharmaceutical companies may also play a role since bio-identical hormones cannot be patented, and patented treatments drive the prescription medication industry. Synthetic hormones, which can increase the risk of certain cancers and heart disease, are regulated by the FDA. As a patient, you can choose a method that works for you. For thousands of women, bio-identical hormone replacement therapy is the answer.